Ursprung des Netzwerks ersten Grades von Kazumasa Akita
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
11
| Public Company | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kazumasa Akita
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
RIBOMIC USA, INC.
 RIBOMIC USA, INC. Pharmaceuticals: MajorHealth Technology Part of Ribomic, Inc., Ribomic USA, Inc. develops aptamer therapeutics. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SANTEN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | President | |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Financial Conglomerates | Director/Board Member | |
| Upjohn Pharmaceuticals Ltd. | Corporate Officer/Principal | ||
Trans Chromosomics, Inc.
 Trans Chromosomics, Inc. Miscellaneous Commercial ServicesCommercial Services Trans Chromosomics, Inc. is a Japanese bio-venture company based on chromosomal engineering technology. The private company, which originated from Tottori University, provides a wide range of TC technology to medical and drug discovery fields, with the aim of contributing to people's lives and health. | Miscellaneous Commercial Services | Director/Board Member | |
Editforce, Inc.
 Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
J-Pharma Co., Ltd.
 J-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 5 |
| Japan | 5 |
Sektoral
| Health Technology | 5 |
| Commercial Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 11 |
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 3 |
| President | 3 |
| Comptroller/Controller/Auditor | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kazumasa Akita
- Unternehmensverbindungen
